Haemonetics (HAE) EBT Margin (2009 - 2026)

Haemonetics' EBT Margin history runs 18 years deep, the most recent figure standing at 8.2% for Q1 2026.

• On a quarterly basis, EBT Margin fell 2960.0% year-over-year to 8.2% in Q1 2026; TTM through Mar 2026 was 9.6%, a 599.0% decrease from a year earlier, with the FY2026 full-year figure at 9.6%, down 599.0% from the prior year.
• EBT Margin fell to 8.2% in Q1 2026 per HAE's latest filing, from 17.69% in the prior quarter.
• Across five years, EBT Margin topped out at 21.4% in Q1 2025 and bottomed at 8.2% in Q1 2026.
• The 5-year median for EBT Margin is 13.45% (2022), against an average of 11.92%.
• Across the five-year window, EBT Margin soared 1796 bps in 2022 and plunged 2960 bps in 2026, its largest moves.
• Year by year, EBT Margin stood at 13.83% in 2022, then slipped by 5 bps to 13.09% in 2023, then increased by 9 bps to 14.32% in 2024, then rose by 24 bps to 17.69% in 2025, then sank by 146 bps to 8.2% in 2026.
• Per Business Quant, the three latest HAE EBT Margin figures stand at 8.2% (Q1 2026), 17.69% (Q4 2025), and 15.67% (Q3 2025).